|
|
|
Volumn 14, Issue 1 SUPPL. 1, 1996, Pages 10-16
|
|
Update on the Dutch Cooperative Trial: Mitomycin versus bacillus Calmette- Guerin-Tice versus bacillus Calmette-Guerin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCG VACCINE;
MITOMYCIN;
ARTICLE;
BLADDER CARCINOMA;
CANCER RECURRENCE;
CARCINOMA IN SITU;
CYSTITIS;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SCREENING;
HUMAN;
INTRAVESICAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
PAPILLARY CARCINOMA;
PRIORITY JOURNAL;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRAVESICAL;
ANTIBIOTICS, ANTINEOPLASTIC;
BCG VACCINE;
CARCINOMA IN SITU;
CARCINOMA, TRANSITIONAL CELL;
COMBINED MODALITY THERAPY;
DENMARK;
HUMANS;
MITOMYCINS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
PROSPECTIVE STUDIES;
SURVIVAL RATE;
URINARY BLADDER NEOPLASMS;
|
|
EID: 0029871855
PISSN: 10810943
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (37)
|
|
References (0)
|
